Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.45%
#2 Venom Venom +25.04%
#3 aelf aelf +15.77%
#4 Decred Decred +10.08%
#5 Status Status +6.67%
#6 Audiera Audiera +6.32%
#7 Wibx Wibx +5.97%
#8 SkyAI SkyAI +5.88%
#9 MarsCoin MarsCoin +5.10%
#10 Talus Network Talus Network +4.84%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Xcell Therapeutics, Inc. Xcell Therapeutics, Inc.

Xcell Therapeutics, Inc.

373110
Rangering i aksjer #30808
Xcell Therapeutics Inc. engages in the development and production of drugs for... Xcell Therapeutics Inc. engages in the development and production of drugs for cell therapy. It offers CellCor, a serum-free chemically defined medium that is used to develop human mesenchymal stem cells. The company also offers XPorT, a platform that aims to develop optimal media from the perspective of the user using a variety of cells. In addition, it develops media for cell culture in various areas of the bioindustry such as cell therapy, gene therapy, exosomes, organoids and bioreactors. Xcell Therapeutics Inc. was founded in 2015 and is based in Seoul, South Korea.
Aksjekurs
$0.87888834
Markedsverdi
$15.20M
Endring (1 dag)
-4.44%
Endring (1 år)
-54.84%
Land
KR
Handel Xcell Therapeutics, Inc. (373110)

Kategori

Healthcare
Utbytteavkastning for Xcell Therapeutics, Inc. (373110)
Xcell Therapeutics, Inc. (aksjesymbol: 373110) sin utbytteavkastning (TTM) per 2026 er: 0
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.00%
Utbytteavkastning for Xcell Therapeutics, Inc. (373110) fra 2026 til 2026
Utbytteavkastning ved slutten av hvert år (TTM)
År Utbytteavkastning Endre
Ikke nok data for de angitte datoene.
Utbytteavkastning (TTM) for lignende selskaper eller konkurrenter
Selskap Utbytteavkastning Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
0.48%
BE